Routine heparin for patients with cancer? One answer, more questions.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  New England Journal of Medicine

• Publication date

  2012-02-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJMe1113672PMID 22335745
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer.

  2012cited by this paper
• Randomized trial of the effect of the low molecular weight heparin nadroparin on survival in patients with cancer.

  2011cited by this paper
• Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation.

  2011cited by this paper
• Heparin as an inhibitor of cancer progression.

  2010cited by this paper

• Anticoagulation for the Prevention of Arterial Thrombosis in Ambulatory Cancer Patients

  2023cites this paper
• The role of coagulome in the tumor immune microenvironment.

  2023cites this paper
• Successful Model for Guideline Implementation to Prevent Successful Model for Guideline Implementation to Prevent Cancer-Associated Thrombosis: Venous Thromboembolism Cancer-Associated Thrombosis: Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic Prevention in the Ambulatory Cancer C

  2023cites this paper
• Improving GRADE evidence tables part 4: a three-arm non-inferiority randomized trial demonstrates improved understanding of content in summary of findings tables with a new format.

  2022cites this paper
• Use of heparin to rescue immunosuppressive monocyte reprogramming by glioblastoma-derived extracellular vesicles.

  2022cites this paper
• Successful Model for Guideline Implementation to Prevent Cancer-Associated Thrombosis: Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic

  2020cites this paper
• Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis.

  2020cites this paper
• Interactive Summary of Findings tables: the way to present and understand results of systematic reviews.

  2019cites this paper
• Neutrophil extracellular traps enhance procoagulant activity in patients with oral squamous cell carcinoma

  2019cites this paper
• Monozytäre Subpopulationen in Patienten mit rheumatoider Arthritis

  2017cites this paper
• Immunogenetic Profiling for Gastric Cancers Identifies Sulfated Glycosaminoglycans as Major and Functional B Cell Antigens in Human Malignancies.

  2017cites this paper
• Gender Differences in Cancer-associated Venous Thromboembolism.

  2017cites this paper
• Improving GRADE evidence tables part 3: detailed guidance for explanatory footnotes supports creating and understanding GRADE certainty in the evidence judgments.

  2016cites this paper
• Safety and efficacy of primary thromboprophylaxis in cancer patients

  2016cites this paper
• Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol

  2016cites this paper
• Contributions of phosphatidylserine-positive platelets and leukocytes and microparticles to hypercoagulable state in gastric cancer patients

  2016cites this paper
• Interpreting GRADE's levels of certainty or quality of the evidence: GRADE for statisticians, considering review information size or less emphasis on imprecision?

  2016cites this paper
• Procoagulant role of neutrophil extracellular traps in patients with gastric cancer.

  2015cites this paper
• Interaction between circulating cancer cells and platelets: clinical implication.

  2015cites this paper
• Verlängert die Heparintherapie das Überleben bei Krebs?

  2015cites this paper
• Clinical guide SEOM on venous thromboembolism in cancer patients

  2014cites this paper
• [Venous thromboembolism and cancer].

  2014cites this paper
• Clinical guide SEOM on venous thromboembolism in cancer patients

  2014cites this paper
• Thromboembolism During Neoadjuvant Therapy for Gastrointestinal Cancer

  2014cites this paper
• Blind Snipers: Relevant Off Target Effects of Non-chemotherapeutic Agents in Oncology: Review of the Literature.

  2014cites this paper
• Clinical Epidemiology and Evidence-Based Health Care

  2014cites this paper
• Clinical models and biochemical predictors of VTE in lung cancer

  2014cites this paper
• Onkologie und Versorgung in Fach- und Publikumsmedien

  2014cites this paper
• Prophylaxie médicamenteuse de la maladie veineuse thromboembolique en soins palliatifs

  2013cites this paper
• Assessing and presenting summaries of evidence in Cochrane Reviews

  2013influential citation
• Potential role of new anticoagulants for prevention and treatment of venous thromboembolism in cancer patients

  2013cites this paper
• Addressing Dichotomous Data for Participants Excluded from Trial Analysis: A Guide for Systematic Reviewers

  2013cites this paper
• [Venous thromboembolism medical thromboprophylaxis in patients admitted to palliative units].

  2013cites this paper
• Onkologie und Versorgung in Fach- und Publikumsmedien

  2013cites this paper
• Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis.

  2013cites this paper
• Biomolecular markers of cancer-associated thromboembolism.

  2013cites this paper
• Are new oral anticoagulants ready for use in patients with cancer?

  2013cites this paper
• Niedermolekulares Heparin senkt Thromboserisiko bei chemotherapeutisch behandelten Tumorpatienten

  2013cites this paper
• [Antithrombotic treatment and cancer].

  2013cites this paper
• Chemotherapy : A Real-World Analysis Venous Thromboembolism Risk in Patients With Cancer

  2013cites this paper
• Niedermolekulares Heparin kann Thromboserisiko senken

  2013cites this paper
• Traitement antithrombotique et cancer

  2013cites this paper
• Repository Assessing and presenting summaries of evidence in Cochrane

  2013cites this paper
• Semuloparin reduced venous thromboembolism in patients receiving chemotherapy for cancer

  2012cites this paper
• Semuloparin helps prevent thromboembolic events in patients receiving chemotherapy.

  2012cites this paper
• Preventing VTE in Outpatients With Cancer: Response

  2012cites this paper
• Preventing Thrombosis During Chemotherapy

  2012cites this paper
• Anticoagulants in cancer

  2012cites this paper
• Thromboprophylaxis Guidelines in Cancer with a Primary Focus on Ambulatory Patients Receiving Chemotherapy: A Review from the Southern Network on Adverse Reactions (SONAR)

  2012cites this paper
• Thrombosis and cancer

  2004cites this paper
• Successful Model for Guideline Implementation to Prevent Successful Model for Guideline Implementation to Prevent Cancer-Associated Thrombosis: Venous Thromboembolism Cancer-Associated Thrombosis: Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic Prevention in the Ambulatory Cancer C

  year unknowncites this paper